↓ Skip to Main Content

the glocalized network in theragenomic and personalized medicine and the genetics of individual patients safety of drugs

search: thasso

Search for:

Log in | Register

Main Navigation

english
thasso
thasso: post
thasso: interactions
thasso: resources
thasso: academy
thasso: about
donations $
Cookie Policy (EU)

Home › Posts tagged Crohn’s Disease

Tag: Crohn’s Disease

With Infliximab (Flixabi), a huge biosimilar medicine has been approved in the European Union (EU)

By Joseph Gut - thasso Posted on June 22, 2016 Posted in New Drug Approval, Thasso Post, Theragenomic Medicine Tagged with Ankylosing Spondylitis, Biosimilar, Crohn's Disease, European Medicines Agency (EMA), Infliximab (Flixabi), Infliximab (Rcmsima), Infliximab [Remicade], Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, Thasso Post, Theragenomic Medicine, Ulcerative Colitis

With Infliximab (Flixabi), a huge biosimilar medicine has been approved in the European Union (EU)

June 22, 2016 – The European Medicines Agency (EMA) has approved, as of the end of May 2016, Infliximab (Flixabi). Infliximab (Flixabi) is a monoclonal antibody that has been designed to attach to a protein called tumour necrosis factor-alpha (TNF-alpha) and block …

With Infliximab (Flixabi), a huge biosimilar medicine has been approved in the European Union (EU) Read more »

Vedolizumab [Entyvio]: FDA approves Entyvio to treat ulcerative colitis and Crohn’s disease

By Joseph Gut - thasso Posted on May 22, 2014 Posted in New Drug Approval, Thasso Post Tagged with American Food & Drug Administration (FDA), Crohn's Disease, Progressive Multifocal Leukoencephalopathy (PML), Thasso Post, Ulcerative Colitis, Vedolizumab [Entyvio]

May 22, 2014 – The U.S. Food and Drug Administration approved on May 20, 2014, Entyvio (vedolizumab) injection to treat adult patients with moderate to severe ulcerative colitis and adult patients with moderate to severe Crohn‘s disease. Entyvio is approved to …

Vedolizumab [Entyvio]: FDA approves Entyvio to treat ulcerative colitis and Crohn’s disease Read more »

Boxed Warning Updated: TNF Blockers and Cancer Risks in Children

By Joseph Gut - thasso Posted on November 3, 2009 Posted in Adverse Drug Reaction [ADR] Tagged with Adalizumab [Humira], Cancer, Certolizumab [Cimzia], Children, Crohn's Disease, Etanercept [Enbrel], Golimumab [Simponi], Infliximab [Remicade], Lymphoma, Rheumatoid Arthritis {Juvenile]

November 3, 2009 – As we learn from it’s todays announcement, FDA is requiring stronger warnings about an increased risk of lymphoma and other cancers in children and adolescents who are treated with drugs that block tumor necrosis factor. TNF …

Boxed Warning Updated: TNF Blockers and Cancer Risks in Children Read more »

In/Out

Log in

Optional: Social Subscribe/Login

thasso: donate

We need your help. Please support the development of thasso through donations. Thank you. Nous avons besoin de votre aide. S'il vous plaît, vous pouvez soutenir le développement de thasso grâce à des dons. Merci. Wir brauchen Ihre Hilfe. Bitte unterstützen Sie die Entwicklung von thasso durch Spenden. Vielen Dank. Abbiamo bisogno del tuo aiuto. Si prega di sostenere lo sviluppo di thasso attraverso donazioni. Grazie. Nós precisamos da sua ajuda. Por favor, apoie o desenvolvimento de thasso através de doações. Obrigada. Necesitamos tu ayuda. Por favor apoye el desarrollo de thasso con donaciones. Muchas gracias.

thasso: conditions

thasso: newest tweets

Tweets by thasso_info

FDA press releases

FDA Roundup: March 24, 2023 March 24, 2023
FDA Works to Further Improve Nutrition, Reduce Diet-Related Chronic Disease with Dietary Guidance Statements on Food Labels March 24, 2023
FDA Issues Draft Guidance Aimed at Improving Oncology Clinical Trials for Accelerated Approval March 24, 2023
FDA Takes Additional Steps to Improve Nutrition, Reduce Disease with Expanded Use of Salt Substitutes to Help Lower Sodium Intake March 24, 2023
FDA Roundup: March 21, 2023 March 21, 2023

FDA MedWatch

Risks with Exactech Joint Replacement Devices with Defective Packaging – FDA Safety Communication March 23, 2023
2023 Safety Communications March 23, 2023
UPDATE: Reports of Squamous Cell Carcinoma (SCC) in the Capsule Around Breast Implants - FDA Safety Communication March 22, 2023
Ascend Laboratories LLC. Issues Voluntary Nationwide Recall of Dabigatran Etexilate Capsules, USP 75 mg and 150 mg, Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity March 22, 2023
2023 Medical Device Recalls March 17, 2023

EMA Press releases

Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 21-22 March 2023, CVMP, 24/03/2023 March 24, 2023
Advancing regulatory science in the EU – mid-point report published, , 22/03/2023 March 22, 2023
EMA Management Board: highlights of March 2023 meeting, MB, 17/03/2023 March 17, 2023
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 13 - 16 March 2023, PRAC, 17/03/2023 March 17, 2023
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 6-8 December 2022, CVMP, 09/12/2022 March 15, 2023

random genetics

VCP/p97 as a therapeutic target in KRAS-mutant pancreatic cancer March 24, 2023
A new research paper, titled "VCP/p97, a pleiotropic protein regulator of the DNA damage response and proteostasis, is a potential therapeutic target in KRAS-mutant pancreatic cancer," was published in Genes & Cancer on March 10, 2023.
Innovative surgical technique creates a nose for patients with 'extremely rare' genetic syndrome March 23, 2023
Congenital arhinia (meaning patients born without a nose) is a rare condition associated with high mortality if not identified. As most babies when born are obligate nose breathers, the condition requires immediate attention. The clinical condition is a very rare genetic disorder that, in severe cases, causes congenital absence of the nose with life threatening […]
Too much pruning: A new study sheds light on how neurodegeneration occurs in the brain March 23, 2023
Just like pruning a tree helps promote proper growth, the brain uses synaptic pruning to get rid of unnecessary connections between its cells. However, when this normal process, which occurs between early childhood and adulthood, doesn't stop properly, the brain loses too many connections, including important ones. Because of this excessive pruning, some brain cells […]
Why does a leukemic mutation not always lead to leukemia? A new clue from a mouse study March 23, 2023
Why do some people with a genetic mutation associated with leukemia remain healthy, while others with the same mutation develop the blood cancer? In a new study published in Blood, scientists from the USC Stem Cell laboratory of Rong Lu discovered a mechanism that linked a leukemic mutation to varying potentials for disease development—a discovery […]
Study finds eye color genes are critical for retinal health March 23, 2023
Metabolic pathways consist of a series of biochemical reactions in cells that convert a starting component into other products. There is growing evidence that metabolic pathways coupled with external stress factors influence the health of cells and tissues. Many human diseases, including retinal or neurodegenerative diseases, are associated with imbalances in metabolic pathways.

Recent Comments

Joseph Gut - thasso on Is there pre-emptive genotyping to avoid adverse drug effects (ADRs)?: “Just testing. https://www.alphamannosidosis.com/en/for-patients-caregivers/disease-information/?utm_source=google&utm_medium=cpc&utm_campaign=AlphamannSearch_Paziente2020&gclid=EAIaIQobChMI2Pv7wNaC_AIVWud3Ch1J8AMPEAAYAiAAEgJGI_D_BwE/” Dec 18, 08:50
Joseph Gut - thasso on Including Africa in the research on rare genetic diseases: A must!: “The genetic diversity of African populations with respect to rare genetic diseases will help to better understand the mechanisms behind…” Dec 18, 04:09
Joseph Gut - thasso on The sixth sense: Are there genes associated with it?: “Does this now work as intended?” Dec 18, 03:55
David Walliams on Is genetic testing of value for ALS patients?: “CURED FROM GENITAL HERPES More than 5 years ago I was in pain with this deadly herpes virus, A few…” Nov 7, 16:08
Raul Malkovic on Is genetic testing of value for ALS patients?: “HOW MY WIFE GOT CURED FROM ALS Below is how i got a cure for my wife who suffered from Amyotrophic Lateral Sclerosis…” Nov 6, 21:18

Tag Cloud

Adverse Drug Reaction (ADR) African American Allelic Variant Allelic Variants American Food & Drug Administration (FDA) American Food & Drug Administration (FDA) Boxed Warning Breast Cancer Canagliflozin (Invokana) Cancer Children Committee for Medicinal Products for Human Use (CHMP) Companion Test Covid-19 Disease Diabetes Drug Induced Liver Injury (DILI) Epidermal Growth Factor Receptor (EGFR) Ethnicity European Medicine Agency (EMA) European Medicines Agency (EMA) Food and Drug Administration (FDA) Gene Therapy Genetic Background Genetic Predisposition Genetic Testing Genotype Health Canada Non-Small Cell Lung Cancer (NSCLC) Pembrolizumab [Keytruda] Personalized Medicine Phenotype Progressive Multifocal Leukoencephalopathy (PML) Rare Disease Risk Evaluation and Mitigation Strategy (REMS) SARS-CoV-2 Schizophrenia Sildenafil [Viagra] Stevens Johnson Syndrome [SJS] Targeted Therapy ThassoBase Thasso Post Theragenomic Medicine Toxic Epidermal Necrolysis (TEN) Type 2 Diabetes Vemurafenib [Zelboraf]

Meta

Register
Log in
Entries feed
Comments feed
WordPress.org

© 2023 Thasso | Powered by Responsive Theme

Manage Cookie Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options Manage services Manage vendors Read more about these purposes

View preferences

{title} {title} {title}